On March 27, Ketu Bio rose 19.99%, and ICBC Consumer Services Hybrid A Fund heavily held this stock.

Securities Star News reports that on March 27, Keta Bio (300858) rose 19.99%, closing at 18.19 yuan, with a turnover rate of 7.81%, a trading volume of 152,900 lots, and a transaction amount of 264 million yuan. This stock is a hot concept related to Helicobacter pylori, the pet economy, feed, food, and soil remediation. On March 27, the capital flow data showed a net inflow of 83.1567 million yuan from main funds, accounting for 31.46% of the total transaction amount, a net outflow of 34.3215 million yuan from retail funds, accounting for 12.98% of the total transaction amount, and a net outflow of 48.8352 million yuan from individual investors, accounting for 18.48% of the total transaction amount.

The public funds heavily invested in Keta Bio are shown in the table below:

According to the 2025 fund annual report’s data on publicly offered fund heavy positions, there are 4 public funds that hold this stock, among which the one with the largest holdings is the ICBC Credit Suisse Fund’s ICBC Consumer Services Mixed A. ICBC Consumer Services Mixed A currently has a scale of 178 million yuan, with a latest net value of 2.348 (March 26), down 1.39% from the previous trading day, and down 5.29% in the past year. The current fund manager of this public fund is Lin Meng. Lin Meng’s fund products under management include: ICBC New Generation Consumer Mixed, managed from July 27, 2018, to present, with a yield of 53.52% during this period;

The top ten heavy positions of ICBC Consumer Services Mixed A are as follows:

The above content is organized by Securities Star based on public information and generated by AI algorithms (Internet Information Office Filing No. 310104345710301240019), and does not constitute investment advice.